Opioid Crisis: Sacklers Pay Billions in New Deal

In a significant move towards addressing the opioid crisis, Purdue Pharma and members of the Sackler family have agreed to shell out up to $7. 4 billion. This deal comes after the Supreme Court rejected an earlier settlement. The Sacklers will contribute as much as $6. 5 billion and also relinquish their ownership of Purdue Pharma. Additionally, Purdue Pharma itself will add nearly $900 million to the pot. This makes it one of the largest settlements in the ongoing legal battle over opioid responsibility. The money will be used to tackle the opioid crisis and support its victims. However, the deal's not a done deal yet; it still needs a judge's stamp of approval. Plus, there's still some fine-tuning to be done on the details. Critics point out that this settlement might not be enough to make up for the damage caused, but it’s definitely a big step in the right direction.